0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Best of the Best |

Top Accessed Article: Successful Treatment of Trichophyton rubrum Nail Bed (Distal Subungual) Onychomycosis FREE

Linda Stein-Gold, MD
[+] Author Affiliations

Author Affiliation: Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.


Arch Dermatol. 2011;147(6):716. doi:10.1001/archdermatol.2011.117.
Text Size: A A A
Published online

Zaias N, Rebell G. Successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis. Arch Dermatol. 2004;140(6):691-695

The article by Zaias and Rebell describes an open-label, prospective, nonrandomized study evaluating pulse dosing with terbinafine at different intervals for the treatment of distal subungual onychomycosis. The authors postulate that terbinafine pulsed over 12 months would provide treatment until the entire mycotic portion of the nail is replaced by normal nail.

Thirty-nine of 42 patients (93%) treated with weekly pulses at 1-, 2-, or 3-month intervals achieved clinical cures based on visual inspection of mycosis-free nails. Patients treated at 4-month intervals had significantly more failures, with 10 of 17 patients clinically cured. Phase 3 studies with terbinafine, 250 mg/d for 12 weeks, a Food and Drug Administration–approved protocol, showed a 39% clinical plus mycological cure rate after 36 weeks of follow-up.1,2

This small study has sparked great interest in the possibility of better efficacy with lower drug exposure and reduced drug cost. Patient compliance over a longer treatment period (12 months) clearly needs to be assessed.

From August 2009, through August 2010, this article was viewed 1772 times on the Archives of Dermatology Web site.

ARTICLE INFORMATION

Contact Dr Stein-Gold at the Department of Dermatology, Henry Ford Health Systems, 3031 W Grand Blvd, Ste 800, Detroit, MI 48202 (lstein1@hfhs.org).

REFERENCES

Drake  LAShear  NHArlette  JP Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial. J Am Acad Dermatol 1997;37 (5, pt 1) 740- 745
PubMed Link to Article
 Lamisil (terbenafine hydrochloride) tablets [package insert].  East Hanover, NJ Novartis Pharmaceuticals Corp1992;

Figures

Tables

References

Drake  LAShear  NHArlette  JP Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial. J Am Acad Dermatol 1997;37 (5, pt 1) 740- 745
PubMed Link to Article
 Lamisil (terbenafine hydrochloride) tablets [package insert].  East Hanover, NJ Novartis Pharmaceuticals Corp1992;

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

267 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs